MARCH1 down-regulation in IL-10-activated B cells increases MHC class II expression

Cytokine

Volumn 59, Issue 1, 2012, Pages 27-30

  Galbas, Tristan ^a   Steimle, Viktor ^b   Lapointe, Réjean ^c   Ishido, Satoshi ^d   Thibodeau, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Research Center for Allergy and Immunology   (Japan)

Author keywords

B cells; IL 10; MARCH1; MHC II; Ubiquitin

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ASSOCIATED RING CH 1 PROTEIN; MESSENGER RNA; TOLL LIKE RECEPTOR 4; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; B-LYMPHOCYTES; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; NIH 3T3 CELLS; RNA, MESSENGER; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

MUS;

EID: 84861706091     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.03.015     Document Type: Article

References (16)

1. de Waal M.R., Haanen J., Spits H., Roncarolo M.G., te V.A., Figdor C., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991, 174:915-924.
2. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991, 146:3444-3451.
3. Jung M., Sabat R., Kratzschmar J., Seidel H., Wolk K., Schonbein C., et al. Expression profiling of IL-10-regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL-10 therapy. Eur J Immunol 2004, 34:481-493.
4. Levy Y., Brouet J.C. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest 1994, 93:424-428.
5. Cohen S.B., Crawley J.B., Kahan M.C., Feldmann M., Foxwell B.M. Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology 1997, 92:1-5.
6. Go N.F., Castle B.E., Barrett R., Kastelein R., Dang W., Mosmann T.R., et al. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990, 172:1625-1631.
7. Thibodeau J., Bourgeois-Daigneault M.C., Huppe G., Tremblay J., Aumont A., Houde M., et al. Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur J Immunol 2008, 38:1225-1230.
8. Matsuki Y., Ohmura-Hoshino M., Goto E., Aoki M., Mito-Yoshida M., Uematsu M., et al. Novel regulation of MHC class II function in B cells. EMBO J 2007, 26:846-854.
9. Eyster C.A., Cole N.B., Petersen S., Viswanathan K., Fruh K., Donaldson J.G. MARCH ubiquitin ligases alter the itinerary of clathrin-independent cargo from recycling to degradation. Mol Biol Cell 2011, 22:3218-3230.
10. Lapointe R., Bellemare-Pelletier A., Housseau F., Thibodeau J., Hwu P. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res 2003, 63:2836-2843.
11. Pillai S., Cariappa A., Moran S.T. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol Rev 2004, 197:206-218.
12. Tze L.E., Horikawa K., Domaschenz H., Howard D.R., Roots C.M., Rigby R.J., et al. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J Exp Med 2011, 208:149-165.
13. Cariappa A., Tang M., Parng C., Nebelitskiy E., Carroll M., Georgopoulos K., et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 2001, 14:603-615.
14. Hillhouse E.E., Beauchamp C., Chabot-Roy G., Dugas V., Lesage S. Interleukin-10 limits the expansion of immunoregulatory CD4-CD8- T cells in autoimmune-prone non-obese diabetic mice. Immunol Cell Biol 2010, 88:771-780.
15. Pierson W., Liston A. A new role for interleukin-10 in immune regulation. Immunol Cell Biol 2010, 88:769-770.
16. Ren S., Zhang F., Li C., Jia C., Li S., Xi H., et al. Selection of housekeeping genes for use in quantitative reverse transcription PCR assays on the murine cornea. Mol Vis 2010, 16:1076-1086.